Beijing-based startup DP Technology Co. Ltd. today outlined a plan to use its artificial intelligence tools to accelerate ...

The Beijing-based AI-for-Science firm said the Series C round would fund hiring and R&D, as interest grows in using AI to ...

When you take a drug, where in your body does it actually go? For most medications, scientists can make only educated guesses ...

Get a behind-the-scenes look at how Regents Professor Gunda Georg led the drug development and its status today.

Instead of building yet another LLM, LeCun is focused on something he sees as more broadly applicable. He wants AI to learn ...

With a strong start to fiscal 2026, NetraMark is reiterating its previously stated guidance of achieving C$8–$10 million in booked contract backlog by mid-2026. This outlook is ...

Chai Discovery has completed a $130 million Series B financing that the artificial intelligence (AI)-based antibody designer says will help it accelerate its research and product development, as well ...

Chai Discovery more than doubled its valuation to $1.3 billion after raising $130 million to advance A.I.-powered drug ...

Less than six months after a series A fundraise, AI drug developer Chai Discovery has brewed up a $130 million series B to ...

NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered ...

Chai Discovery, the AI company that predicts and reprograms the interactions between biochemical molecules, today announced its $130 million Series B financing round co-led by Oak HC/FT and General ...

Cellular, animal and computational models of the disease are providing fresh insights into biology and treatment.